序号 |
标题 |
次数 |
作者 |
发布时间 |
83656 |
EuropiuM DOTA SodiuM Salt Hydrate |
97 |
zyl |
2024-11-28 |
83657 |
CAS:753421-63-5 4-Aminobutyl-DOTA |
83 |
zyl |
2024-11-28 |
83658 |
Pteroyl-Lys-DOTA ,蝶酰-Lys-DOTA DOTA缀合的蝶酰-Lys衍生物 |
114 |
kx |
2024-11-28 |
83659 |
丙烯酸乙酯与丙烯酰胺接枝淀粉/β-环糊精树脂 EA-AM/β-CD |
100 |
h |
2024-11-28 |
83660 |
VIP-DOTA(靶向VPAC2-R) |
155 |
kx |
2024-11-28 |
83661 |
大环造影剂CAS:2126179-28-8;Ho-p-SCN-Bn-DOTA |
99 |
zyl |
2024-11-28 |
83662 |
Na[Gd(DOTA)·H2O]大环配合物 |
118 |
kx |
2024-11-28 |
83663 |
44Sc-DOTA-ZHER2:2891 , 亲和体分子ZHER2:2891偶联DOTA螯合剂 |
179 |
kx |
2024-11-28 |
83664 |
3,6-二胍基-1,2,4,5-四嗪高氯酸盐[DGTz·2(HClO4)] |
118 |
WYQ |
2024-11-28 |
83665 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
91 |
zyl |
2024-11-28 |
83666 |
β-环糊精改性聚(氯甲基苯乙烯)树脂 β-CD/PS-Cl |
95 |
h |
2024-11-28 |
83667 |
3,6-二肼基-1,2,4,5-四嗪3,5-二硝基水杨酸盐二水合物(DHTz·DNSA-2H2O) |
144 |
WYQ |
2024-11-28 |
83668 |
DOTA-TOC,204318-14-9,依多曲肽 |
106 |
zcy |
2024-11-28 |
83669 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
102 |
zyl |
2024-11-28 |
83670 |
β-环糊精改性机蒙脱七跟环氧树脂 E-44-β-CD |
165 |
h |
2024-11-28 |
83671 |
86Y-DOTA-Bn , 钇-86-DOTA-铃蟾肽 |
131 |
kx |
2024-11-28 |
83672 |
Gd-NOTA;钆-大环配体NOTA |
104 |
zcy |
2024-11-28 |
83673 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
178 |
WYQ |
2024-11-28 |
83674 |
环糊精改性的脲醛树脂 CD-UF |
114 |
h |
2024-11-28 |
83675 |
CAS:177943-89-4 DOTATATE acetate |
156 |
zyl |
2024-11-28 |
83676 |
CAS:137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
119 |
zyl |
2024-11-28 |
83677 |
3,6-双(1H-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
99 |
WYQ |
2024-11-28 |
83678 |
3-甲基-5-芳基吡唑,3,4−e 并-1,2,3,4-四嗪衍生物 |
108 |
WYQ |
2024-11-28 |
83679 |
β-环糊精改性聚对二氧环己酮/聚乙烯醇水凝胶 β-CD-PPDO/PVA |
154 |
h |
2024-11-28 |
83680 |
DOTA-PAMAMG3.0-SH ,DOTA-PAMAMG3.0-巯基, DOTA偶联巯基化聚酰胺-胺(PAMAM)树形分子 |
117 |
kx |
2024-11-28 |
83681 |
3,3′-偶氮-1,2,4,5-四嗪衍生物 |
103 |
WYQ |
2024-11-28 |
83682 |
β-环糊精/Fe3O4/氧化石墨烯 |
119 |
h |
2024-11-28 |
83683 |
DOTA-PEG-CRGD环肽;大环配体DOTA-聚乙二醇-CRGD |
89 |
zcy |
2024-11-28 |
83684 |
3,6-二胍基-1,2,4,5-四嗪(DGTz) |
128 |
WYQ |
2024-11-28 |
83685 |
β-环糊精-聚丙烯酰胺水凝胶 β-CD-PAM |
160 |
h |
2024-11-28 |
83686 |
Iron DOTA Sodium Salt |
111 |
zyl |
2024-11-28 |
83687 |
环糊精-聚丙烯酸复合水凝胶 β-CD/PAA |
122 |
h |
2024-11-28 |
83688 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
107 |
WYQ |
2024-11-28 |
83689 |
DOTA-c(RGDfK);具有特定生物活性的多肽分子 |
97 |
zcy |
2024-11-28 |
83690 |
1,2,3,4-四嗪-1,3-二氧化物 |
103 |
WYQ |
2024-11-28 |
83691 |
3,6-双(1H-1,2,4-三唑-3-氨基)-1,2,4,5-四嗪 |
96 |
WYQ |
2024-11-28 |
83692 |
3,6-双-(3,5-二氨基-1,2,4-三唑基)-1,2,4,5-四嗪(BTDTz) |
105 |
WYQ |
2024-11-28 |
83693 |
β-环糊精交联聚丙烯酸水凝胶 β-CD-6-A |
92 |
h |
2024-11-28 |
83694 |
DOTA-Tyr-3/temozolomide ,Dota-Tyr-3/替莫唑胺 |
93 |
kx |
2024-11-28 |
83695 |
3,6-二氯-1,2,4,5-四嗪(BCT) |
128 |
WYQ |
2024-11-28 |
83696 |
大豆多糖/β-环糊精三维纳米水凝胶 SSPS/β-CD |
127 |
h |
2024-11-28 |
83697 |
DOTA-3-酪氨酰基-奥曲肽,多肽化合物177943-89-4 |
91 |
zcy |
2024-11-28 |
83698 |
180978-54-5,DOTA-p-NH2-Bn-Biotin,DOTA-生物素-肌氨酸 |
101 |
zcy |
2024-11-28 |
83699 |
DOTA-Ala-Ala-Tyr-COOH;DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
100 |
zcy |
2024-11-28 |
83700 |
Ln-DOTA-Dimedone |
129 |
kx |
2024-11-28 |